Kadysh, Nicholas

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 153% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kadysh, Nicholas's trades of Pharmala Biotech Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
256.80
Quantity 60,183 -49.0%
Value CA$4,164,655
Transaction date
Purchase
Price
96.10
Quantity 61,676 -8.5%
Value CA$4,087,548
Transaction date
Purchase
Price
339.67
Quantity 22,724 +21.6%
Value CA$2,071,710
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-19 2024-04-19
B Purchase
60,183 -49.0%
256.80
CA$4,164,655 		60,183 -49.0% 256.80 CA$4,164,655
2023-03-28 2023-03-28
B Purchase
61,676 -8.5%
96.10
CA$4,087,548 		61,676 -8.5% 96.10 CA$4,087,548
2023-02-23 2023-02-23
B Purchase
22,724 +21.6%
339.67
CA$2,071,710 		22,724 +21.6% 339.67 CA$2,071,710